Helsinki, Finland

Tuomas Tammela

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Vegenics Pty Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tuomas Tammela. Retrieved from https://idiyas.com/inventor/tuomas-tammela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tuomas Tammela

Introduction

Tuomas Tammela is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic methods. His work focuses on enhancing angiogenic properties through modified polypeptides.

Latest Patents

Tuomas Tammela holds a patent for "Modified VEGF-A with improved angiogenic properties." This invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules retain VEGFR-2 binding activity and exhibit enhanced angiogenic activity compared to native VEGF-A. He has 1 patent to his name.

Career Highlights

Tuomas is associated with Vegenics Pty Limited, where he continues to advance his research and development efforts. His work has implications for therapeutic applications in various medical fields, particularly in treating conditions related to blood vessel formation.

Collaborations

Throughout his career, Tuomas has collaborated with esteemed colleagues such as Kari Alitalo and Salla Keskitalo. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in biotechnology.

Conclusion

Tuomas Tammela's contributions to the field of biotechnology through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…